FI941169A - Lipidisoitujen proteiinien transvaskulaarinen ja intracellulaarinen antaminen - Google Patents
Lipidisoitujen proteiinien transvaskulaarinen ja intracellulaarinen antaminen Download PDFInfo
- Publication number
- FI941169A FI941169A FI941169A FI941169A FI941169A FI 941169 A FI941169 A FI 941169A FI 941169 A FI941169 A FI 941169A FI 941169 A FI941169 A FI 941169A FI 941169 A FI941169 A FI 941169A
- Authority
- FI
- Finland
- Prior art keywords
- transvascular
- intracellular administration
- lipidized proteins
- lipidized
- proteins
- Prior art date
Links
- 230000003834 intracellular effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91245392A | 1992-07-13 | 1992-07-13 | |
| PCT/US1993/006599 WO1994001131A1 (en) | 1992-07-13 | 1993-07-13 | Transvascular and intracellular delivery of lipidized proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI941169A0 FI941169A0 (fi) | 1994-03-11 |
| FI941169A true FI941169A (fi) | 1994-05-04 |
Family
ID=25431949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI941169A FI941169A (fi) | 1992-07-13 | 1994-03-11 | Lipidisoitujen proteiinien transvaskulaarinen ja intracellulaarinen antaminen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0607408A4 (ru) |
| JP (1) | JPH07502753A (ru) |
| KR (2) | KR100372119B1 (ru) |
| AU (1) | AU4772793A (ru) |
| CA (1) | CA2118586A1 (ru) |
| FI (1) | FI941169A (ru) |
| NZ (1) | NZ255043A (ru) |
| OA (1) | OA09893A (ru) |
| RU (1) | RU2157239C2 (ru) |
| WO (1) | WO1994001131A1 (ru) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5543390A (en) * | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
| US5827819A (en) * | 1990-11-01 | 1998-10-27 | Oregon Health Sciences University | Covalent polar lipid conjugates with neurologically active compounds for targeting |
| US6020526A (en) * | 1995-07-21 | 2000-02-01 | Genta, Incorporated | Amide-based cationic lipids |
| US7045543B2 (en) | 2001-11-05 | 2006-05-16 | Enzrel Inc. | Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites |
| AU2003205615B2 (en) | 2002-01-10 | 2008-09-25 | Universiteit Gent | A novel splice variant of MyD88 and uses thereof |
| EP1488804A4 (en) * | 2002-03-22 | 2006-10-25 | Bipha Corp | HYDROPHILIC PEPTIDE COMPLEXES - IMMUNOGLOBULIN |
| US8044100B2 (en) | 2004-12-22 | 2011-10-25 | Bellus Health Inc. | Methods and compositions for treating amyloid-related diseases |
| WO2007082899A1 (en) | 2006-01-17 | 2007-07-26 | Vib Vzw | Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
| US8217145B2 (en) * | 2006-03-16 | 2012-07-10 | The Scrips Research Institute | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| CN103787927B (zh) | 2006-10-12 | 2017-03-01 | Bhi有限合资公司 | 递送3‑氨基‑1‑丙磺酸的方法、化合物、组合物和载体 |
| WO2008055924A1 (en) | 2006-11-07 | 2008-05-15 | Vib Vzw | Diagnosis and treatment of t-cell acute lymphoblastic leukemia |
| EP2096121A1 (en) * | 2008-02-29 | 2009-09-02 | Institut Pasteur Of Shanghai | Antiviral peptides comprising lipid attachment signals and methods of use |
| CA2736729A1 (en) | 2008-09-29 | 2010-04-01 | Ben Gurion University Of The Negev Research And Development Authority | Amyloid beta-peptides and methods of use thereof |
| US20130149297A1 (en) | 2010-07-02 | 2013-06-13 | Vib Vzw | Role of fragile x mental retardation gene and protein in cancer metastasis |
| GB201012845D0 (en) | 2010-07-30 | 2010-09-15 | Vib Vzw | Inhibition of dicer function for treatment of cancer |
| AR083495A1 (es) * | 2010-10-22 | 2013-02-27 | Esbatech Alcon Biomed Res Unit | Anticuerpos estables y solubles |
| CA2884580A1 (en) | 2011-09-14 | 2013-03-21 | Abeterno Limited | Intracellular cell selection |
| WO2013121042A1 (en) | 2012-02-16 | 2013-08-22 | Vib Vzw | PP2A SUBUNITS IN DNA REPAIR, THE PP2A B55α SUBUNIT AS NOVEL PHD2 INTERACTING PROTEIN, AND IMPLICATIONS FOR CANCER |
| GB201306589D0 (en) | 2013-04-11 | 2013-05-29 | Abeterno Ltd | Live cell imaging |
| JP6736464B2 (ja) | 2013-08-29 | 2020-08-05 | シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ | 細胞透過性コンジュゲート及びその使用の方法 |
| KR101470793B1 (ko) * | 2014-06-30 | 2014-12-08 | 순천향대학교 산학협력단 | 흡수촉진제로서의 펩타이드와 이를 포함하는 조성물 |
| EP3634978A1 (en) | 2017-06-07 | 2020-04-15 | Adrx, Inc. | Tau aggregation inhibitors |
| EP3668886A2 (en) | 2017-08-18 | 2020-06-24 | Adrx, Inc. | Tau aggregation peptide inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4429008B1 (en) * | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
| EP0306912A3 (en) * | 1987-09-08 | 1989-07-05 | Albany Medical College | Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same. |
| ES2055907T3 (es) * | 1989-03-07 | 1994-09-01 | Genentech Inc | Conjugados covalentes de lipidos y oligonucleotidos. |
| DK0478715T3 (da) * | 1989-06-23 | 1996-08-05 | Liposome Co Inc | Målrettede liposomer og fremgangsmåder til liposom-protein-kobling |
| US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| AU647814B2 (en) * | 1990-07-24 | 1994-03-31 | Seikagaku Kogyo Kabushiki Kaisha | Phospholipid- or lipid-combining glycosaminoglycan, production thereof, and cancer metastasis inhibitor |
-
1993
- 1993-07-13 EP EP93918190A patent/EP0607408A4/en not_active Withdrawn
- 1993-07-13 NZ NZ255043A patent/NZ255043A/en unknown
- 1993-07-13 CA CA002118586A patent/CA2118586A1/en not_active Abandoned
- 1993-07-13 KR KR1019940700829A patent/KR100372119B1/ko not_active IP Right Cessation
- 1993-07-13 AU AU47727/93A patent/AU4772793A/en not_active Abandoned
- 1993-07-13 KR KR1020027011377A patent/KR20030097604A/ko not_active Application Discontinuation
- 1993-07-13 JP JP6503580A patent/JPH07502753A/ja active Pending
- 1993-07-13 WO PCT/US1993/006599 patent/WO1994001131A1/en not_active Application Discontinuation
- 1993-07-13 RU RU94024566/14A patent/RU2157239C2/ru not_active IP Right Cessation
-
1994
- 1994-03-11 OA OA60481A patent/OA09893A/en unknown
- 1994-03-11 FI FI941169A patent/FI941169A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030097604A (ko) | 2003-12-31 |
| RU2157239C2 (ru) | 2000-10-10 |
| EP0607408A4 (en) | 1997-12-10 |
| KR100372119B1 (ko) | 2003-06-28 |
| EP0607408A1 (en) | 1994-07-27 |
| OA09893A (en) | 1994-09-15 |
| RU94024566A (ru) | 1996-09-27 |
| JPH07502753A (ja) | 1995-03-23 |
| NZ255043A (en) | 1997-03-24 |
| WO1994001131A1 (en) | 1994-01-20 |
| CA2118586A1 (en) | 1994-01-20 |
| AU4772793A (en) | 1994-01-31 |
| FI941169A0 (fi) | 1994-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI941169A (fi) | Lipidisoitujen proteiinien transvaskulaarinen ja intracellulaarinen antaminen | |
| FI932722A0 (fi) | Glukagonlika peptider och insulinotropinderivat | |
| FI932960A0 (fi) | Kontroll av frukters mogning och vaexters foeraoldring | |
| FI935485A0 (fi) | PEG-hydrazon- och PEG-oximbindningen bildande reagens och proteinderivat daerav | |
| ATE276762T1 (de) | Stabile lyophilisierte pharmazeutische zubereitungen von mono- oder polykonalen antikörpern | |
| IT1224421B (it) | Galattomannani modificati e realtivo procedimento di preparazione | |
| DE69322062T2 (de) | Emulsionspolymere und ihre verwendung in haarfestigungszubereitungen | |
| ITRM930503A0 (it) | Costruzione combinata di affisso e di catalogo. | |
| FI960353A (fi) | Ihmisen interleukiini-10:n agonistit ja antagonistit | |
| NO964758D0 (no) | Anvendelse av von Willebrand-faktor og farmasöytiske preparater | |
| DK56891D0 (da) | Anvendelse af pesticidpraeparater | |
| FI954491A (fi) | Heterosykliä sisältäviä amidiinijohdokset, niiden valmistus ja käyttö | |
| ITMI921413A0 (it) | Preparazioni farmaceutiche stabili di nicorandil | |
| FI932114A0 (fi) | Maolspecifika erytrocyter och tromboerytrocyter | |
| NO973826D0 (no) | Ny anvendelse av preparater inneholdende perlemor | |
| FI935789A0 (fi) | Anlaeggning och foerfarande foer braenning av explosiva aemnen | |
| DE69616889D1 (de) | Kompression von Bewegtbildern | |
| SE458083B (sv) | Elradiator och anvaendning av densamma | |
| BR9106742A (pt) | Preparacao de pentafluoretos de niobio e de tantalo anidros | |
| FI920758A (fi) | Komposition och dessa anvaendning saosom biocid | |
| DK82592D0 (da) | Fremstilling af proteiner | |
| NO940877D0 (no) | Transvasculær og intracellulær avgivelse av lipidiserte proteiner | |
| FI971086A0 (fi) | Kinaasia sitova proteiini ja sen käyttö | |
| AU2372197A (en) | Transvascular and intracellular delivery of lipidized proteins | |
| IT9048305A0 (it) | Complesso di profilati con estremita' e profilati d'angolo raccordati curvi |